Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
A Longitudinal Study of COVID-19 Sequelae and Immunity

Some people who get COVID-19 have only mild symptoms. But for others, infection leads to pneumonia, respiratory failure, and, in some cases, death. Researchers want to learn more about any effects that may persist after people recover from COVID-19.

covid-19
pulmonary function tests
SARS
respiratory failure
white blood cell count
  • 0 views
  • 16 Feb, 2024
  • 1 location
Direct and Indirect Impact of COVID-19 In Older Populations

This study propose to describe risk factors for acute and long term mortality of COVID 19 in patients up to 70 years old.

  • 0 views
  • 05 Aug, 2020
Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients

Previous studies claims that the proportion of mean platellet volume to platellet which can simply be determined with simple blood tests that are performed at admission, might predict the mortality in ARDS patients. Covid-19 pneumonia has a very similar clinical outlook with ARDS. Therefore we decided to research whether that …

pneumonia
acute respiratory distress
covid-19
acute respiratory distress syndrome
blood test
  • 0 views
  • 16 Feb, 2024
  • 1 location
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of COVID-19 pneumonia.

pneumonia
covid-19
antiviral drugs
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 16 Feb, 2024
  • 1 location
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

In December 2019, a pneumonia due to a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, in China. In a few weeks, the number of confirmed cases of SARS-CoV-2 infection has dramatically increased, with almost 150'000 cases and more than 6'000 reported deaths on March, 16th 2020.

pneumonia
covid-19
coronavirus infection
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 16 Feb, 2024
  • 17 locations
Development of a Simple Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV

In late December 2019, several local health facilities reported clusters of patients with pneumonia of unknown cause that were epidemiologically linked to a seafood and wet animal wholesale market in Wuhan, Hubei Province, China.

  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19: Study of INFLAmmasome and PLAtelets Functions

COVID-19 pandemic is a severe viral sepsis characterized by the occurrence of Acute respiratory distress syndrome (ARDS) whose pathophysiology is little described

covid-19
acute respiratory distress
respiratory distress
viraemia
inflammasome
  • 0 views
  • 05 Aug, 2020
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients

This is an observational study designed to learn more about how COVID19 convalescent plasma works in patients with COVID19 compared to those patients who did not receive convalescent plasma treatment. Information about patient recovery will be collected from participants' electronic medical records to evaluate safety, clinical outcomes, and SARS-CoV2 antibody …

respiratory symptom
SARS
acute respiratory syndrome (sars)
  • 0 views
  • 16 Feb, 2024
  • 6 locations
Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);

This study aims to observe the long-term health-related quality of life (HRQOL) and physical performance in individuals hospitalized due to a COVID-19 infection. Therefore, data is extracted from a study-site standard aftercare program which has been adjusted for this patient population. This comprehensive aftercare program includes education sessions and physical …

  • 0 views
  • 05 Aug, 2020
HFNC and NIV for COVID-19 Complicated by Respiratory Failure

Background: Patients with COVID-19 have a range of clinical spectrum from asymptomatic infection, mild illness, moderate infection requiring supplemental oxygen and severe infection requiring intensive care support. High flow nasal cannula (HFNC) oxygen therapy and noninvasive ventilation (NIV) may offer respiratory support to patients with COVID-19 complicated by acute hypoxemic …

covid-19
respiratory therapy
acute respiratory failure
acute respiratory syndrome (sars)
respiratory failure
  • 0 views
  • 16 Feb, 2024
  • 1 location